Literature DB >> 19739039

Microparticles and arterial disease.

Andrew Blann1, Eduard Shantsila, Alena Shantsila.   

Abstract

Microparticles (MPs) are small (diameter <1 microm) fragments that seem likely to represent some form of physiology and/or pathophysiology of the originating cell, be it endothelial, platelet, or leukocyte. Increased numbers of MPs are found in various disease states, including cardiovascular disease, and a considerable weight of literature suggests a value in dissecting the various aspects of cell biology. A role in coagulation has been proposed because there is evidence that some MPs expose tissue factor. This article reviews the definitions, mechanisms of production, and links with pathophysiology of MPs in arterial disease, and thus whether or not they can contribute to improved patient care. Copyright Thieme Medical Publishers.

Entities:  

Mesh:

Year:  2009        PMID: 19739039     DOI: 10.1055/s-0029-1234144

Source DB:  PubMed          Journal:  Semin Thromb Hemost        ISSN: 0094-6176            Impact factor:   4.180


  11 in total

1.  Endothelial microparticles induce inflammation in acute lung injury.

Authors:  Keely L Buesing; John C Densmore; Sushma Kaul; Kirkwood A Pritchard; Jason A Jarzembowski; David M Gourlay; Keith T Oldham
Journal:  J Surg Res       Date:  2010-06-09       Impact factor: 2.192

2.  Microparticles Impair Hypotensive Cerebrovasodilation and Cause Hippocampal Neuronal Cell Injury after Traumatic Brain Injury.

Authors:  Leif-Erik Bohman; John Riley; Tatyana N Milovanova; Matthew R Sanborn; Stephen R Thom; William M Armstead
Journal:  J Neurotrauma       Date:  2015-07-31       Impact factor: 5.269

3.  Arterial and venous thrombosis in cancer patients.

Authors:  Andrew D Blann; Simon Dunmore
Journal:  Cardiol Res Pract       Date:  2011-03-03       Impact factor: 1.866

4.  A rabbit model of thrombosis on atherosclerotic lesions.

Authors:  Atsushi Yamashita; Yujiro Asada
Journal:  J Biomed Biotechnol       Date:  2010-12-26

5.  Racial differences in tumor necrosis factor-α-induced endothelial microparticles and interleukin-6 production.

Authors:  Michael D Brown; Deborah L Feairheller; Sunny Thakkar; Praveen Veerabhadrappa; Joon-Young Park
Journal:  Vasc Health Risk Manag       Date:  2011-08-26

6.  Remote ischemic preconditioning in the prevention of ischemic brain damage during intracranial aneurysm treatment (RIPAT): study protocol for a randomized controlled trial.

Authors:  Selma Tülü; Miriam Mulino; Daniel Pinggera; Markus Luger; Philipp Würtinger; Astrid Grams; Thomas Bodner; Ronny Beer; Raimund Helbok; Raffaella Matteucci-Gothe; Claudia Unterhofer; Elke Gizewski; Erich Schmutzhard; Claudius Thomé; Martin Ortler
Journal:  Trials       Date:  2015-12-29       Impact factor: 2.279

7.  Hemocompatibility of Inorganic Physical Vapor Deposition (PVD) Coatings on Thermoplastic Polyurethane Polymers.

Authors:  Juergen M Lackner; Wolfgang Waldhauser; Paul Hartmann; Franz Bruckert; Marianne Weidenhaupt; Roman Major; Marek Sanak; Martin Wiesinger; Daniel Heim
Journal:  J Funct Biomater       Date:  2012-04-17

Review 8.  Endothelial microparticles act as novel diagnostic and therapeutic biomarkers of circulatory hypoxia-related diseases: a literature review.

Authors:  Fan Deng; Shuang Wang; Liangqing Zhang
Journal:  J Cell Mol Med       Date:  2017-03-18       Impact factor: 5.310

Review 9.  Brain-Heart Interaction: Cardiac Complications After Stroke.

Authors:  Zhili Chen; Poornima Venkat; Don Seyfried; Michael Chopp; Tao Yan; Jieli Chen
Journal:  Circ Res       Date:  2017-08-04       Impact factor: 17.367

10.  Clinical CVVH model removes endothelium-derived microparticles from circulation.

Authors:  Abdelhafeez H Abdelhafeez; Paul M Jeziorczak; Terry R Schaid; Susan L Hoefs; Sushma Kaul; Rahul Nanchal; Elizabeth R Jacobs; John C Densmore
Journal:  J Extracell Vesicles       Date:  2014-02-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.